Alluvi Glow GHK-Cu (10mg / 10mg / 50mg) | Research-Grade Triple-Agonist Peptide

£100.00

Alluvi Retatrutide offers high-purity, research-grade peptide formulations available in stated 10mg, 10mg multi-unit, and high-yield 50mg analytical presentations. Engineered for laboratory and in-vitro study, Retatrutide is an investigational triple-receptor agonist targeting GLP-1, GIP, and glucagon pathways to support reproducible metabolic and receptor-binding research. Strictly for laboratory R&D use.

Alluvi Retatrutide presentations—available in 10mg, 10mg calibrated formats, and 50mg high-yield quantities—are prepared specifically for controlled scientific investigation and analytical workflows. Retatrutide is an investigational synthetic multi-agonist peptide designed to simultaneously engage three critical metabolic pathway systems:

  • GLP-1 (Glucagon-Like Peptide-1): Enables targeted study of incretin mimetic activity, cellular signaling cascades, and receptor dynamics.

  • GIP (Glucose-Dependent Insulinotropic Polypeptide): Facilitates investigation into dual-incretin interactions and downstream biochemical signaling.

  • Glucagon Receptor: Provides an analytical model for glucagon counter-regulatory pathways, energy expenditure mechanics, and lipid substrate interactions.

The availability of varying quantity tiers (from single 10mg vials to 50mg institutional research batches) ensures flexible procurement for both small-scale screening assays and extensive, multi-variable laboratory protocols.

Product Specifications

Parameter Specification
Product Name Alluvi Retatrutide
Manufacturer Alluvi Healthcare
Available Strengths 10mg / 10mg (Calibrated) / 50mg
Receptor Profile GLP-1 / GIP / Glucagon triple agonist
Form Lyophilized powder / Laboratory solution
Intended Grade Non-clinical R&D / Analytical investigation

Core Laboratory Research Applications

  • Comparative binding affinity assays across GLP-1, GIP, and glucagon receptor complexes

  • In-vitro signal transduction and secondary messenger (cAMP) profiling

  • High-throughput metabolic pathway cross-talk and receptor synergy studies

  • Formulation resilience, stability modeling, and peptide degradation profiling

Storage & Handling Protocol

  • Store refrigerated at 2°C to 8°C immediately upon delivery (or at -20°C for long-term dry powder storage).

  • Minimize exposure to room temperature, direct ambient light, and repeated freeze-thaw cycles once reconstituted.

  • Match and record container lot numbers with relevant analytical certificates of analysis (CoA) prior to experiment initiation.

  • Handle using standard laboratory PPE and compliant biosafety equipment.

Packaging & Cold-Chain Dispatch

  • Shipped using temperature-controlled cold-chain packaging to ensure compound stability.

  • Delivered in plain, tamper-evident outer packaging for batch security and integrity.

  • Stored in continuously monitored refrigerated conditions prior to order processing.

Research Use Only (RUO) Notice

Laboratory Notice: Alluvi Retatrutide (10mg / 50mg) is supplied strictly for in-vitro scientific research, laboratory assays, and non-clinical analytical development. This compound is not a drug, dietary product, or medical treatment. It is strictly prohibited for human consumption, clinical application, or veterinary administration.

Tablets

20

Reviews

There are no reviews yet.

Be the first to review “Alluvi Glow GHK-Cu (10mg / 10mg / 50mg) | Research-Grade Triple-Agonist Peptide”
Scroll to Top